Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
In this model, employees obtain GLP-1 prescriptions via eMeds telehealth platform (with remote monitoring), and then split the cost of the drugs with the employer at discounted rates
A recent randomized study just published in the Lancet in 2025 evaluated 194 folks randomly assigned to Exenatide (n=97) or placebo (n=97)
In pre-specified analyses for time to first occurrence of MACE, there were 44 MACE-5 (all-cause death, heart attack, stroke, heart failure event, or coronary revascularization ) events observed in participants randomized to retatrutide (pooled 9 mg and 12 mg) and 52 events observed in those randomized to placebo, resulting in a hazard ratio of 0.82 (95.0% CI: 0.55 to 1.22)
In contrast, the powerful beta cell action of exendin-phe1 provides a potential means to avoid tolerability issues associated with high doses of other agents, and might therefore be a novel therapeutic option for T2D
US$ 25.96
US$ 25.62
US$ 21.83
US$ 21.10
US$ 23.40
US$ 27.23
US$ 28.10
US$ 28.82
